gamma-Aminobutyric Acid A Receptor Agonist [EPC]

gamma-Aminobutyric Acid A Receptor Agonist [EPC] was reported 1619 times

Drugs of the gamma-Aminobutyric Acid A Receptor Agonist [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 DIGESTIVE ENZYME INCREASED 1 0.1111
1 CELL MARKER DECREASED 1 0.0370
2 BENZODIAZEPINE DRUG LEVEL 1 0.0333
3 DIFFUSE LARGE B-CELL LYMPHOMA STAGE I 1 0.0238
4 RADICULITIS LUMBOSACRAL 2 0.0180
5 ABSCESS OF EYELID 1 0.0179
6 HLA-B*27 POSITIVE 2 0.0143
7 ASSISTED SUICIDE 1 0.0143
8 ANTIDIURETIC HORMONE ABNORMALITY 1 0.0119
9 RADICULITIS 2 0.0119
10 ALLERGY TO IMMUNOGLOBULIN THERAPY 1 0.0092
11 BURSA DISORDER 2 0.0069
12 DERMATOCHALASIS 1 0.0068
13 ADMINISTRATION SITE SWELLING 2 0.0062
14 AMINO ACID LEVEL DECREASED 2 0.0059
15 EPIDURAL LIPOMATOSIS 2 0.0058
16 BASILAR ARTERY THROMBOSIS 1 0.0056
17 BIPOLAR II DISORDER 2 0.0056
18 SLEEP-RELATED EATING DISORDER 5 0.0053
19 DEAFNESS PERMANENT 1 0.0051
20 CONDUCT DISORDER 1 0.0049
21 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 5 0.0047
22 FRONTOTEMPORAL DEMENTIA 2 0.0047
23 ALCOHOL WITHDRAWAL SYNDROME 4 0.0046
24 PERINATAL DEPRESSION 2 0.0044
25 SLEEP ATTACKS 2 0.0042
26 PARASOMNIA 3 0.0042
27 IMMUNODEFICIENCY COMMON VARIABLE 2 0.0041
28 COLONIC OBSTRUCTION 1 0.0038
29 EPIRETINAL MEMBRANE 1 0.0036
30 NERVE ROOT COMPRESSION 2 0.0035
31 ALLERGY TO ARTHROPOD BITE 1 0.0031
32 ACUTE STRESS DISORDER 1 0.0030
33 CUBITAL TUNNEL SYNDROME 1 0.0029
34 INFUSION SITE DISCOMFORT 3 0.0029
35 ADMINISTRATION SITE BRUISE 1 0.0029
36 ANION GAP DECREASED 1 0.0029
37 CYSTITIS ESCHERICHIA 1 0.0028
38 ANKLE ARTHROPLASTY 1 0.0028
39 SYSTEMIC SCLERODERMA 2 0.0027
40 DRY AGE-RELATED MACULAR DEGENERATION 3 0.0027
41 ESSENTIAL TREMOR 3 0.0027
42 NEPHROGENIC ANAEMIA 12 0.0026
43 PRE-EXISTING CONDITION IMPROVED 16 0.0026
44 ENDOMETRIAL HYPERPLASIA 2 0.0025
45 SOMNAMBULISM 16 0.0024
46 LIP DISCOLOURATION 3 0.0024
47 ELEVATED MOOD 1 0.0023
48 INFUSION SITE DISCHARGE 4 0.0023
49 TERMINAL INSOMNIA 4 0.0023
50 CHRONIC CUTANEOUS LUPUS ERYTHEMATOSUS 1 0.0022
51 ALLERGY TO PLANTS 1 0.0022
52 CHONDROLYSIS 1 0.0021
53 AUTOIMMUNE MYOSITIS 1 0.0021
54 PELVIC DISCOMFORT 2 0.0021
55 INFUSION SITE NODULE 2 0.0021
56 BLOOD CREATINE ABNORMAL 1 0.0021
57 BRAIN STEM STROKE 1 0.0020
58 HYPERPARATHYROIDISM SECONDARY 5 0.0020
59 CENTRAL NERVOUS SYSTEM VASCULITIS 1 0.0020
60 SINUSITIS BACTERIAL 2 0.0019
61 ALLERGY TO ANIMAL 2 0.0019
62 EOSINOPHIL PERCENTAGE INCREASED 1 0.0018
63 EJACULATION DELAYED 1 0.0018
64 ENCEPHALOMALACIA 1 0.0018
65 BURNING MOUTH SYNDROME 1 0.0018
66 LUMBAR RADICULOPATHY 2 0.0017
67 DROP ATTACKS 1 0.0017
68 COLON CANCER STAGE IV 1 0.0017
69 DYSMETRIA 1 0.0017
70 NARCOLEPSY 3 0.0016
71 ABDOMINAL COMPARTMENT SYNDROME 1 0.0016
72 ACTIVITIES OF DAILY LIVING DECREASED 1 0.0016
73 CEREBRAL SMALL VESSEL ISCHAEMIC DISEASE 1 0.0015
74 EXTRADURAL HAEMATOMA 2 0.0015
75 HYPOVITAMINOSIS 2 0.0015
76 ALCOHOL ABUSE 4 0.0015
77 NASAL DISCHARGE DISCOLOURATION 2 0.0014
78 THERAPEUTIC PROCEDURE 2 0.0014
79 HANGOVER 5 0.0014
80 CATAPLEXY 2 0.0014
81 INFUSION SITE BRUISING 3 0.0014
82 DISSOCIATIVE DISORDER 1 0.0014
83 BLOOD FOLATE DECREASED 1 0.0014
84 HYPOTHALAMO-PITUITARY DISORDER 2 0.0014
85 OBSTRUCTIVE SLEEP APNOEA SYNDROME 2 0.0014
86 CLONIC CONVULSION 1 0.0014
87 SLEEP APNOEA SYNDROME 26 0.0014
88 GENERALISED ANXIETY DISORDER 2 0.0014
89 HYPOMANIA 5 0.0014
90 AGE-RELATED MACULAR DEGENERATION 2 0.0013
91 DIAPHRAGMATIC DISORDER 1 0.0013
92 NEURITIS 2 0.0013
93 BLOOD KETONE BODY INCREASED 1 0.0013
94 DRUG TOLERANCE INCREASED 1 0.0013
95 SUSPECTED SUICIDE 6 0.0013
96 CORNEAL TRANSPLANT 1 0.0013
97 PHARYNGEAL PARAESTHESIA 2 0.0013
98 BREAST CALCIFICATIONS 1 0.0013
99 INFUSION SITE HAEMORRHAGE 4 0.0012
100 CIRCADIAN RHYTHM SLEEP DISORDER 1 0.0012
101 SALMONELLOSIS 2 0.0012
102 POST PROCEDURAL HAEMATOMA 2 0.0012
103 DEAFNESS TRANSITORY 1 0.0012
104 COLONIC ABSCESS 1 0.0012
105 ENDOCRINE OPHTHALMOPATHY 1 0.0012
106 BLOOD TRIGLYCERIDES ABNORMAL 1 0.0011
107 EMOTIONAL POVERTY 2 0.0011
108 BREAST CYST 2 0.0011
109 DETACHMENT OF RETINAL PIGMENT EPITHELIUM 1 0.0011
110 DRUG DETOXIFICATION 1 0.0011
111 ANAEMIA OF CHRONIC DISEASE 1 0.0011
112 CERUMEN IMPACTION 1 0.0011
113 ADVERSE FOOD REACTION 1 0.0011
114 CATHETER SITE SWELLING 1 0.0011
115 BONE CYST 1 0.0011
116 BRAIN STEM HAEMORRHAGE 1 0.0011
117 COMPLETED SUICIDE 88 0.0011
118 COLON NEOPLASM 1 0.0010
119 BLADDER CATHETERISATION 1 0.0010
120 PULMONARY PAIN 3 0.0010
121 PRODUCT ADMINISTRATION INTERRUPTED 8 0.0010
122 SMALL INTESTINAL HAEMORRHAGE 2 0.0010
123 BREAST DISORDER 2 0.0010
124 AXILLARY MASS 1 0.0010
125 INFUSION SITE PRURITUS 3 0.0009
126 NEUROGENIC BLADDER 2 0.0009
127 MULTIPLE DRUG OVERDOSE INTENTIONAL 3 0.0009
128 GASTRIC BYPASS 2 0.0009
129 CLAUSTROPHOBIA 1 0.0009
130 AORTIC DILATATION 1 0.0009
131 CALCINOSIS 2 0.0009
132 FEAR OF DEATH 2 0.0009
133 IDIOPATHIC INTRACRANIAL HYPERTENSION 2 0.0009
134 BENIGN NEOPLASM 1 0.0009
135 DRUG EFFECT VARIABLE 1 0.0009
136 CORTISOL DECREASED 1 0.0009
137 DYSLEXIA 1 0.0009
138 ADMINISTRATION SITE PAIN 1 0.0009
139 CEREBRAL VENTRICLE DILATATION 1 0.0009
140 TACHYPHRENIA 3 0.0009
141 ACUTE PRERENAL FAILURE 1 0.0009
142 SEASONAL ALLERGY 12 0.0008
143 RADIUS FRACTURE 2 0.0008
144 DENTAL OPERATION 2 0.0008
145 APPLICATION SITE SCAR 1 0.0008
146 SNORING 3 0.0008
147 PARANASAL SINUS DISCOMFORT 3 0.0008
148 BAND SENSATION 1 0.0008
149 ENDODONTIC PROCEDURE 2 0.0008
150 INITIAL INSOMNIA 8 0.0008
151 THERAPEUTIC PRODUCT EFFECT VARIABLE 3 0.0008
152 HERNIA REPAIR 2 0.0008
153 ABNORMAL SLEEP-RELATED EVENT 1 0.0008
154 ENURESIS 3 0.0007
155 CLUSTER HEADACHE 1 0.0007
156 CORNEAL ABRASION 1 0.0007
157 SPINAL STENOSIS 3 0.0007
158 EOSINOPHILIC OESOPHAGITIS 2 0.0007
159 VENTRICULAR FIBRILLATION 8 0.0007
160 CHRONIC FATIGUE SYNDROME 1 0.0007
161 SELF-INJURIOUS IDEATION 3 0.0007
162 PANCREATIC CARCINOMA METASTATIC 2 0.0007
163 GASTROINTESTINAL NECROSIS 2 0.0007
164 THERAPEUTIC REACTION TIME DECREASED 2 0.0007
165 AUTONOMIC NERVOUS SYSTEM IMBALANCE 2 0.0007
166 MAJOR DEPRESSION 5 0.0007
167 ANKLE OPERATION 1 0.0007
168 RHINITIS ALLERGIC 3 0.0007
169 METABOLIC ENCEPHALOPATHY 2 0.0007
170 VARICES OESOPHAGEAL 2 0.0007
171 REBOUND ACID HYPERSECRETION 2 0.0007
172 THROMBOPHLEBITIS SUPERFICIAL 2 0.0007
173 INTERVERTEBRAL DISC DEGENERATION 6 0.0006
174 BACTERIAL VAGINOSIS 1 0.0006
175 SKIN ABRASION 3 0.0006
176 DRUG EFFECT INCREASED 2 0.0006
177 ANTICHOLINERGIC SYNDROME 1 0.0006
178 INFUSION SITE PAIN 8 0.0006
179 LOOSE TOOTH 2 0.0006
180 CARDIOVASCULAR INSUFFICIENCY 1 0.0006
181 DECUBITUS ULCER 5 0.0006
182 DENTAL IMPLANTATION 1 0.0006
183 FOOT OPERATION 3 0.0006
184 CHRONIC KIDNEY DISEASE 46 0.0006
185 MULTIPLE DRUG OVERDOSE 3 0.0006
186 ARTHROPOD STING 1 0.0006
187 VEIN DISORDER 3 0.0006
188 DEMENTIA ALZHEIMER'S TYPE 1 0.0006
189 CHOLECYSTITIS CHRONIC 4 0.0006
190 POST-TRAUMATIC STRESS DISORDER 4 0.0006
191 DIFFICULTY IN WALKING 2 0.0006
192 AORTIC STENOSIS 2 0.0006
193 SPINAL OSTEOARTHRITIS 5 0.0006
194 APPENDICECTOMY 2 0.0006
195 FACIAL BONES FRACTURE 2 0.0006
196 DEVICE ALARM ISSUE 1 0.0006
197 SPONDYLITIS 2 0.0005
198 END STAGE RENAL DISEASE 10 0.0005
199 DRUG DOSE TITRATION NOT PERFORMED 1 0.0005
200 MOUTH HAEMORRHAGE 4 0.0005
201 INTESTINAL ISCHAEMIA 3 0.0005
202 BODY TEMPERATURE ABNORMAL 1 0.0005
203 FREEZING PHENOMENON 2 0.0005
204 BLOOD CHOLESTEROL DECREASED 1 0.0005
205 MIDDLE INSOMNIA 10 0.0005
206 SEDATION 14 0.0005
207 ADENOCARCINOMA OF COLON 1 0.0005
208 GRANULOCYTOPENIA 3 0.0005
209 DERMATITIS CONTACT 6 0.0005
210 PARANASAL SINUS HYPERSECRETION 2 0.0005
211 VISUAL DISTURBANCE 3 0.0005
212 TENDONITIS 8 0.0005
213 FAECES HARD 2 0.0005
214 ADRENOCORTICAL INSUFFICIENCY ACUTE 1 0.0005
215 POOR QUALITY SLEEP 11 0.0005
216 AFFECTIVE DISORDER 4 0.0005
217 GLUCOSE TOLERANCE IMPAIRED 3 0.0005
218 CEREBRAL ATROPHY 2 0.0005
219 BLEPHARITIS 2 0.0005
220 EJACULATION FAILURE 1 0.0005
221 SPINAL FUSION SURGERY 2 0.0005
222 SINUS TACHYCARDIA 7 0.0005
223 DEVICE DEPOSIT ISSUE 1 0.0005
224 SUBSTANCE ABUSE 4 0.0005
225 SCOLIOSIS 3 0.0005
226 CAPILLARY LEAK SYNDROME 1 0.0005
227 INFUSION SITE EXTRAVASATION 3 0.0005
228 INFUSION SITE SWELLING 3 0.0005
229 HALLUCINATIONS, MIXED 2 0.0005
230 PHOTOPSIA 3 0.0005
231 VITAMIN D DECREASED 4 0.0005
232 SHOULDER OPERATION 2 0.0005
233 LEFT VENTRICULAR HYPERTROPHY 2 0.0005
234 ASPIRATION 5 0.0005
235 CORNEAL DISORDER 1 0.0005
236 DIABETIC NEPHROPATHY 1 0.0005
237 BLOOD CREATINE INCREASED 2 0.0005
238 CATHETERISATION CARDIAC 2 0.0005
239 RESPIRATORY RATE INCREASED 4 0.0005
240 DIVERTICULUM INTESTINAL HAEMORRHAGIC 1 0.0004
241 URINARY TRACT DISORDER 2 0.0004
242 COMPLICATIONS OF TRANSPLANTED KIDNEY 1 0.0004
243 IMPAIRED GASTRIC EMPTYING 6 0.0004
244 THERAPEUTIC PRODUCT EFFECT DELAYED 2 0.0004
245 HUNGER 6 0.0004
246 FEELING OF DESPAIR 2 0.0004
247 SURGERY 25 0.0004
248 SKIN TIGHTNESS 2 0.0004
249 VENTRICULAR TACHYCARDIA 7 0.0004
250 HAND FRACTURE 3 0.0004
251 SPINAL DISORDER 4 0.0004
252 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO DEVICE USE ERROR 1 0.0004
253 PRE-ECLAMPSIA 2 0.0004
254 UTERINE LEIOMYOMA 3 0.0004
255 AUTOIMMUNE DISORDER 4 0.0004
256 VITAMIN D DEFICIENCY 4 0.0004
257 ORAL DISORDER 3 0.0004
258 COELIAC DISEASE 4 0.0004
259 DERMAL CYST 1 0.0004
260 LOWER GASTROINTESTINAL HAEMORRHAGE 3 0.0004
261 SPRUE-LIKE ENTEROPATHY 2 0.0004
262 HYPERVOLAEMIA 2 0.0004
263 DISABILITY 8 0.0004
264 LIGAMENT SPRAIN 4 0.0004
265 FEELING DRUNK 3 0.0004
266 DEVICE INFUSION ISSUE 1 0.0004
267 CATHETER SITE HAEMORRHAGE 1 0.0004
268 CORONARY ARTERY STENOSIS 2 0.0004
269 DRUG TOLERANCE 2 0.0004
270 ABDOMINAL INFECTION 1 0.0004
271 FOOD ALLERGY 3 0.0004
272 CONCUSSION 3 0.0004
273 DRUG TITRATION ERROR 1 0.0004
274 APHTHOUS ULCER 3 0.0004
275 PELVIC FRACTURE 3 0.0004
276 MULTIPLE ALLERGIES 3 0.0004
277 SCIATICA 6 0.0004
278 PHARYNGOLARYNGEAL PAIN 2 0.0004
279 ANIMAL BITE 1 0.0004
280 ANGIONEUROTIC OEDEMA 1 0.0004
281 GASTROINTESTINAL MOTILITY DISORDER 2 0.0004
282 SENSORY LOSS 3 0.0004
283 RENAL INJURY 11 0.0004
284 HIP SURGERY 2 0.0004
285 POST PROCEDURAL INFECTION 3 0.0004
286 ANORGASMIA 1 0.0004
287 BIPOLAR DISORDER 4 0.0004
288 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 2 0.0004
289 PERIPHERAL COLDNESS 5 0.0004
290 DEAFNESS UNILATERAL 2 0.0004
291 CYSTIC FIBROSIS 2 0.0004
292 CHOLECYSTITIS INFECTIVE 1 0.0004
293 EOSINOPHIL COUNT INCREASED 3 0.0004
294 DIABETIC COMA 1 0.0004
295 IMPAIRED DRIVING ABILITY 4 0.0004
296 GENERALISED ERYTHEMA 2 0.0004
297 MICTURITION URGENCY 4 0.0003
298 CARDIAC VALVE DISEASE 2 0.0003
299 SKIN ATROPHY 2 0.0003
300 SOCIAL AVOIDANT BEHAVIOUR 2 0.0003
301 COMA SCALE ABNORMAL 1 0.0003
302 HYPERVENTILATION 2 0.0003
303 SKIN WARM 2 0.0003
304 ANHEDONIA 9 0.0003
305 CATARACT OPERATION 2 0.0003
306 GALLBLADDER DISORDER 6 0.0003
307 MYOCLONUS 4 0.0003
308 GASTROINTESTINAL INFECTION 3 0.0003
309 MYOSITIS 3 0.0003
310 CENTRAL VENOUS CATHETERISATION 1 0.0003
311 HALLUCINATION, VISUAL 7 0.0003
312 LIMB INJURY 9 0.0003
313 CRANIOCEREBRAL INJURY 1 0.0003
314 ATRIOVENTRICULAR BLOCK SECOND DEGREE 1 0.0003
315 NOCTURIA 4 0.0003
316 NEURALGIA 8 0.0003
317 TENSION 2 0.0003
318 DISORIENTATION 13 0.0003
319 CHEST X-RAY ABNORMAL 1 0.0003
320 DUODENITIS 1 0.0003
321 MENISCUS INJURY 2 0.0003
322 UROSEPSIS 3 0.0003
323 SPINAL OPERATION 4 0.0003
324 DIASTOLIC DYSFUNCTION 1 0.0003
325 DRUG DIVERSION 2 0.0003
326 APPENDICITIS 3 0.0003
327 NASAL DRYNESS 2 0.0003
328 NIGHTMARE 11 0.0003
329 BRAIN OEDEMA 4 0.0003
330 BREAST CANCER RECURRENT 1 0.0003
331 FOOT FRACTURE 6 0.0003
332 FEELING JITTERY 6 0.0003
333 TOOTH DISORDER 7 0.0003
334 HALLUCINATION, AUDITORY 5 0.0003
335 FOREIGN BODY SENSATION IN EYES 2 0.0003
336 INSOMNIA 83 0.0003
337 CUSHINGOID 1 0.0003
338 ROTATOR CUFF SYNDROME 4 0.0003
339 HIATUS HERNIA 4 0.0003
340 SUICIDAL IDEATION 28 0.0003
341 POLYP 2 0.0003
342 PSYCHOTIC DISORDER 9 0.0003
343 DEAFNESS NEUROSENSORY 1 0.0003
344 PULMONARY CONGESTION 4 0.0003
345 MENINGITIS 2 0.0003
346 BREAST MASS 2 0.0003
347 TOOTH ABSCESS 3 0.0003
348 DIABETIC RETINOPATHY 1 0.0003
349 MOTOR DYSFUNCTION 3 0.0003
350 MIGRAINE 28 0.0003
351 EUPHORIC MOOD 3 0.0003
352 SINUSITIS 30 0.0003
353 PRODUCT PREPARATION ERROR 6 0.0003
354 RIB FRACTURE 6 0.0003
355 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 5 0.0003
356 DROOLING 2 0.0003
357 BLOOD CREATININE ABNORMAL 1 0.0003
358 LARGE INTESTINE POLYP 2 0.0003
359 FIBROMYALGIA 7 0.0003
360 FORMICATION 2 0.0003
361 APHONIA 4 0.0003
362 CARPAL TUNNEL SYNDROME 4 0.0003
363 INTENTIONAL PRODUCT USE ISSUE 25 0.0003
364 KNEE ARTHROPLASTY 6 0.0003
365 HEAD INJURY 9 0.0003
366 DIVERTICULUM 2 0.0003
367 CONJUNCTIVAL HYPERAEMIA 1 0.0003
368 BODY HEIGHT DECREASED 3 0.0003
369 PRODUCT SUPPLY ISSUE 2 0.0003
370 HIP FRACTURE 9 0.0003
371 DEVICE PLACEMENT ISSUE 1 0.0003
372 ANXIETY 79 0.0003
373 BONE LESION 1 0.0003
374 GASTROENTERITIS VIRAL 5 0.0003
375 VISUAL FIELD DEFECT 2 0.0003
376 CLOSTRIDIUM DIFFICILE INFECTION 6 0.0003
377 BLOOD PHOSPHORUS DECREASED 1 0.0003
378 RENAL FAILURE 36 0.0003
379 DRUG EFFECT LESS THAN EXPECTED 4 0.0003
380 MALNUTRITION 3 0.0003
381 TOXICITY TO VARIOUS AGENTS 45 0.0003
382 TUBULOINTERSTITIAL NEPHRITIS 5 0.0003
383 AUTOIMMUNE THYROIDITIS 1 0.0003
384 ECONOMIC PROBLEM 4 0.0003
385 INTENTIONAL PRODUCT MISUSE 23 0.0003
386 COMMUNICATION DISORDER 1 0.0003
387 CLAVICLE FRACTURE 1 0.0003
388 DISSOCIATION 2 0.0003
389 PROCEDURAL COMPLICATION 2 0.0003
390 PRODUCT SUBSTITUTION ISSUE 15 0.0003
391 ANKLE FRACTURE 4 0.0003
392 PRESCRIBED OVERDOSE 5 0.0003
393 APNOEA 2 0.0003
394 HAEMORRHAGIC STROKE 2 0.0003
395 TORSADE DE POINTES 2 0.0003
396 ABNORMAL DREAMS 7 0.0003
397 DIVERTICULITIS 7 0.0003
398 SINUS DISORDER 5 0.0003
399 ABNORMAL BEHAVIOUR 10 0.0003
400 RESPIRATORY TRACT CONGESTION 4 0.0003
401 OBESITY 4 0.0003
402 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 12 0.0002
403 NIGHT SWEATS 8 0.0002
404 RHINITIS 2 0.0002
405 MUSCLE TIGHTNESS 4 0.0002
406 FALL 82 0.0002
407 BACK DISORDER 4 0.0002
408 THERAPEUTIC RESPONSE UNEXPECTED 11 0.0002
409 HYPERAESTHESIA 2 0.0002
410 BLOOD PRESSURE INCREASED 37 0.0002
411 CONGESTIVE CARDIOMYOPATHY 1 0.0002
412 ATTENTION DEFICIT HYPERACTIVITY DISORDER 1 0.0002
413 DEPRESSION 54 0.0002
414 INFUSION SITE ERYTHEMA 2 0.0002
415 OSTEOARTHRITIS 10 0.0002
416 ACUTE KIDNEY INJURY 36 0.0002
417 CARDIAC FAILURE CHRONIC 1 0.0002
418 ABSCESS LIMB 1 0.0002
419 JOINT INJURY 5 0.0002
420 ALCOHOLISM 1 0.0002
421 SOMNOLENCE 47 0.0002
422 PRODUCT CONTAINER ISSUE 2 0.0002
423 HYPERHIDROSIS 30 0.0002
424 CARDIAC OPERATION 2 0.0002
425 MUSCULOSKELETAL DISCOMFORT 4 0.0002
426 MUSCLE STRAIN 2 0.0002
427 CARDIAC MURMUR 2 0.0002
428 CHAPPED LIPS 1 0.0002
429 RESPIRATORY TRACT INFECTION 6 0.0002
430 DIVERTICULUM INTESTINAL 1 0.0002
431 FEELING HOT 14 0.0002
432 BEDRIDDEN 3 0.0002
433 ANKYLOSING SPONDYLITIS 3 0.0002
434 GRIP STRENGTH DECREASED 2 0.0002
435 HALLUCINATION 17 0.0002
436 JOINT RANGE OF MOTION DECREASED 3 0.0002
437 ORAL PAIN 5 0.0002
438 DRY EYE 11 0.0002
439 DRUG TOXICITY 3 0.0002
440 RESTLESS LEGS SYNDROME 4 0.0002
441 AKATHISIA 3 0.0002
442 CYSTITIS 7 0.0002
443 EXOSTOSIS 2 0.0002
444 RESTLESSNESS 8 0.0002
445 CENTRAL NERVOUS SYSTEM LESION 3 0.0002
446 BLOOD PRESSURE DIASTOLIC INCREASED 1 0.0002
447 UPPER RESPIRATORY TRACT INFECTION 10 0.0002
448 ARTHRITIS 17 0.0002
449 PRODUCT DISTRIBUTION ISSUE 2 0.0002
450 SUICIDE ATTEMPT 13 0.0002
451 FLANK PAIN 2 0.0002
452 DEVICE OCCLUSION 3 0.0002
453 GASTROOESOPHAGEAL REFLUX DISEASE 17 0.0002
454 CHRONIC LYMPHOCYTIC LEUKAEMIA 1 0.0002
455 INTENTIONAL DOSE OMISSION 6 0.0002
456 CARDIAC TAMPONADE 1 0.0002
457 FUNGAL INFECTION 7 0.0002
458 ENDOMETRIOSIS 1 0.0002
459 INCREASED APPETITE 4 0.0002
460 IMPAIRED QUALITY OF LIFE 3 0.0002
461 POST PROCEDURAL COMPLICATION 4 0.0002
462 PARAESTHESIA ORAL 3 0.0002
463 PRESYNCOPE 5 0.0002
464 DYSSTASIA 6 0.0002
465 KNEE OPERATION 2 0.0002
466 APPLICATION SITE BURN 1 0.0002
467 BREATH SOUNDS ABNORMAL 1 0.0002
468 DIABETIC NEUROPATHY 1 0.0002
469 BLADDER DISORDER 2 0.0002
470 ABDOMINAL TENDERNESS 1 0.0002
471 IMMUNODEFICIENCY 3 0.0002
472 OVARIAN CYST 2 0.0002
473 HYPOAESTHESIA ORAL 3 0.0002
474 TREMOR 33 0.0002
475 COLORECTAL CANCER STAGE III 1 0.0002
476 EMPHYSEMA 2 0.0002
477 PRODUCT ADMINISTRATION ERROR 4 0.0002
478 OSTEOPENIA 3 0.0002
479 VAGINAL DISCHARGE 2 0.0002
480 HYPOTHERMIA 2 0.0002
481 CORONARY ARTERIAL STENT INSERTION 1 0.0002
482 DRY THROAT 2 0.0002
483 INSURANCE ISSUE 3 0.0002
484 FEELING ABNORMAL 47 0.0002
485 SLUGGISHNESS 2 0.0002
486 ENDOCARDITIS 1 0.0002
487 ILLNESS 20 0.0002
488 LIMB DISCOMFORT 6 0.0002
489 MUSCULOSKELETAL CHEST PAIN 3 0.0002
490 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
491 POOR VENOUS ACCESS 2 0.0002
492 DIPLOPIA 5 0.0002
493 EYE DISCHARGE 2 0.0002
494 TENDERNESS 2 0.0002
495 WITHDRAWAL SYNDROME 8 0.0002
496 PRODUCT USE COMPLAINT 3 0.0002
497 HYPOTHYROIDISM 6 0.0002
498 RETCHING 4 0.0002
499 INTENTIONAL OVERDOSE 12 0.0002
500 CONTUSION 18 0.0002
501 SENSORY DISTURBANCE 3 0.0002
502 HYPOACUSIS 8 0.0002
503 ANAL ABSCESS 1 0.0002
504 BALANCE DISORDER 16 0.0002
505 UNEVALUABLE EVENT 14 0.0002
506 THROAT TIGHTNESS 5 0.0002
507 OEDEMA 10 0.0002
508 PULMONARY THROMBOSIS 2 0.0002
509 MOOD ALTERED 5 0.0002
510 TREATMENT NONCOMPLIANCE 10 0.0002
511 TOOTH FRACTURE 2 0.0002
512 CHOKING SENSATION 1 0.0002
513 DRUG LEVEL BELOW THERAPEUTIC 1 0.0002
514 DENTAL CARIES 2 0.0002
515 PSYCHOMOTOR HYPERACTIVITY 3 0.0002
516 FOOT DEFORMITY 2 0.0002
517 SKIN DISORDER 6 0.0002
518 MUSCLE SPASMS 33 0.0002
519 AGGRESSION 9 0.0002
520 WOUND 5 0.0002
521 OCULAR DISCOMFORT 2 0.0002
522 BLOOD CALCIUM DECREASED 2 0.0002
523 EYE PAIN 10 0.0002
524 EYE INFECTION 2 0.0002
525 AGITATION 13 0.0002
526 CHOLECYSTITIS ACUTE 1 0.0002
527 URINARY TRACT INFECTION 30 0.0002
528 MULTIPLE SCLEROSIS RELAPSE 12 0.0002
529 HYPERSOMNIA 5 0.0002
530 TINNITUS 8 0.0002
531 MUSCLE TWITCHING 4 0.0002
532 SPLENOMEGALY 2 0.0002
533 SEXUAL DYSFUNCTION 2 0.0002
534 DECREASED INTEREST 1 0.0002
535 ENERGY INCREASED 1 0.0002
536 COVID-19 PNEUMONIA 2 0.0002
537 TREATMENT FAILURE 14 0.0002
538 NEUROPATHY PERIPHERAL 16 0.0002
539 ACCIDENT 2 0.0002
540 DISTURBANCE IN ATTENTION 9 0.0002
541 ELECTROCARDIOGRAM QT PROLONGED 6 0.0002
542 INFUSION RELATED REACTION 11 0.0002
543 OSTEOMYELITIS 3 0.0002
544 LOCALISED INFECTION 4 0.0002
545 CRYING 6 0.0002
546 BURSITIS 2 0.0002
547 PANIC ATTACK 6 0.0002
548 DERMATITIS ACNEIFORM 1 0.0002
549 VERTIGO 10 0.0002
550 LOSS OF CONSCIOUSNESS 21 0.0002
551 RESPIRATORY DEPRESSION 2 0.0002
552 DYSURIA 6 0.0002
553 CARDIOMEGALY 2 0.0002
554 CONCOMITANT DISEASE AGGRAVATED 1 0.0002
555 TENDON RUPTURE 2 0.0002
556 CYST 2 0.0002
557 HEPATIC STEATOSIS 3 0.0002
558 NECK PAIN 9 0.0002
559 TOOTH EXTRACTION 2 0.0002
560 MEMORY IMPAIRMENT 22 0.0002
561 POISONING 2 0.0002
562 BLOOD SODIUM DECREASED 3 0.0002
563 BLEPHAROSPASM 1 0.0002
564 COLITIS 6 0.0002
565 INJECTION SITE IRRITATION 2 0.0002
566 GAIT DISTURBANCE 30 0.0002
567 LETHARGY 9 0.0002
568 MYDRIASIS 2 0.0002
569 SLEEP DISORDER 11 0.0002
570 HERNIA 3 0.0002
571 UNRESPONSIVE TO STIMULI 4 0.0002
572 CARDIAC FLUTTER 1 0.0002
573 DYSTONIA 3 0.0002
574 HAEMATOMA 4 0.0002
575 COVID-19 27 0.0002
576 DYSPHONIA 9 0.0002
577 ANGINA UNSTABLE 1 0.0002
578 HYPOAESTHESIA 23 0.0002
579 NERVOUSNESS 8 0.0002
580 KIDNEY INFECTION 3 0.0002
581 DYSGRAPHIA 1 0.0002
582 BLOOD PRESSURE ABNORMAL 3 0.0002
583 THERAPEUTIC RESPONSE SHORTENED 5 0.0002
584 BACK PAIN 35 0.0002
585 UPPER LIMB FRACTURE 3 0.0002
586 BLOOD PRESSURE DECREASED 10 0.0002
587 EAR INFECTION 4 0.0002
588 VIRAL INFECTION 5 0.0002
589 LIP SWELLING 5 0.0001
590 CARDIAC FAILURE ACUTE 1 0.0001
591 URINARY RETENTION 5 0.0001
592 INJECTION SITE PRURITUS 10 0.0001
593 SINUS CONGESTION 2 0.0001
594 PSORIATIC ARTHROPATHY 6 0.0001
595 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 1 0.0001
596 COMA 7 0.0001
597 HEPATIC ENZYME INCREASED 10 0.0001
598 ABNORMAL LOSS OF WEIGHT 1 0.0001
599 BLOOD TESTOSTERONE DECREASED 1 0.0001
600 ECCHYMOSIS 1 0.0001
601 INJECTION SITE WARMTH 3 0.0001
602 CORONARY ARTERY OCCLUSION 2 0.0001
603 SKIN LESION 4 0.0001
604 APPLICATION SITE RASH 2 0.0001
605 NAUSEA 115 0.0001
606 MENTAL STATUS CHANGES 4 0.0001
607 AUTOIMMUNE HEPATITIS 1 0.0001
608 INTENTIONAL DRUG MISUSE 3 0.0001
609 COORDINATION ABNORMAL 2 0.0001
610 DEMENTIA 4 0.0001
611 DUODENAL ULCER 1 0.0001
612 CONDITION AGGRAVATED 43 0.0001
613 PAIN IN JAW 4 0.0001
614 HEPATOCELLULAR INJURY 2 0.0001
615 PRODUCT QUALITY ISSUE 19 0.0001
616 PARALYSIS 2 0.0001
617 OVERDOSE 30 0.0001
618 CELLULITIS 7 0.0001
619 MENTAL DISORDER 6 0.0001
620 FLUSHING 14 0.0001
621 DRUG EFFECT INCOMPLETE 5 0.0001
622 FLUID RETENTION 7 0.0001
623 FLUID OVERLOAD 2 0.0001
624 RESPIRATORY FAILURE 10 0.0001
625 APATHY 2 0.0001
626 NASAL CONGESTION 8 0.0001
627 WEIGHT DECREASED 38 0.0001
628 CONFUSIONAL STATE 22 0.0001
629 BLINDNESS TRANSIENT 1 0.0001
630 DRY MOUTH 11 0.0001
631 INJECTION SITE MASS 5 0.0001
632 TACHYCARDIA 12 0.0001
633 DEHYDRATION 18 0.0001
634 ARTHROPOD BITE 1 0.0001
635 SKIN HAEMORRHAGE 2 0.0001
636 CATARACT 8 0.0001
637 PULMONARY MASS 2 0.0001
638 RASH PAPULAR 3 0.0001
639 THERAPY NON-RESPONDER 6 0.0001
640 CARDIAC ARREST 11 0.0001
641 BLOOD POTASSIUM DECREASED 4 0.0001
642 CHROMATURIA 3 0.0001
643 DYSARTHRIA 5 0.0001
644 HEART RATE IRREGULAR 3 0.0001
645 LACRIMATION INCREASED 4 0.0001
646 HYPERTENSION 28 0.0001
647 AORTIC ANEURYSM 1 0.0001
648 DISCOMFORT 8 0.0001
649 WHITE BLOOD CELL COUNT INCREASED 5 0.0001
650 DRUG EFFECT DECREASED 7 0.0001
651 THYROID DISORDER 2 0.0001
652 HYPOTENSION 26 0.0001
653 HEADACHE 81 0.0001
654 DELUSION 2 0.0001
655 SWOLLEN TONGUE 4 0.0001
656 BONE DENSITY DECREASED 4 0.0001
657 BRAIN FOG 2 0.0001
658 DRUG-INDUCED LIVER INJURY 4 0.0001
659 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
660 PARAESTHESIA 20 0.0001
661 BLOOD ALBUMIN DECREASED 1 0.0001
662 PRODUCT DOSE OMISSION ISSUE 37 0.0001
663 PREMATURE DELIVERY 2 0.0001
664 CARDIAC FAILURE CONGESTIVE 10 0.0001
665 ASTHMA 14 0.0001
666 VISION BLURRED 17 0.0001
667 FLATULENCE 7 0.0001
668 BLOOD POTASSIUM INCREASED 2 0.0001
669 DYSKINESIA 5 0.0001
670 AMNESIA 8 0.0001
671 ASPHYXIA 1 0.0001
672 DIZZINESS 61 0.0001
673 BRONCHITIS 9 0.0001
674 MANIA 2 0.0001
675 OSTEOPOROSIS 5 0.0001
676 SEIZURE 14 0.0001
677 BLOOD ALKALINE PHOSPHATASE INCREASED 3 0.0001
678 ROAD TRAFFIC ACCIDENT 5 0.0001
679 BLOOD UREA INCREASED 2 0.0001
680 HOT FLUSH 9 0.0001
681 DRUG USE DISORDER 1 0.0001
682 UPPER GASTROINTESTINAL HAEMORRHAGE 2 0.0001
683 MALAISE 52 0.0001
684 ANGER 4 0.0001
685 HEMIPARESIS 2 0.0001
686 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 2 0.0001
687 SWELLING 11 0.0001
688 PAIN 72 0.0001
689 THERAPY CESSATION 6 0.0001
690 HAEMATURIA 4 0.0001
691 IRRITABILITY 7 0.0001
692 SKIN ULCER 3 0.0001
693 PARANOIA 2 0.0001
694 THERAPEUTIC RESPONSE DECREASED 7 0.0001
695 DELIRIUM 4 0.0001
696 OEDEMA PERIPHERAL 14 0.0001
697 ORTHOSTATIC HYPOTENSION 2 0.0001
698 LOCAL SWELLING 2 0.0001
699 DEVICE USE ISSUE 2 0.0001
700 BURNING SENSATION 8 0.0001
701 HYPERKALAEMIA 4 0.0001
702 BLOOD CALCIUM INCREASED 1 0.0001
703 DRUG WITHDRAWAL SYNDROME 10 0.0001
704 NASOPHARYNGITIS 21 0.0001
705 METASTASES TO LIVER 2 0.0001
706 DEPRESSED MOOD 6 0.0001
707 ABDOMINAL DISCOMFORT 19 0.0001
708 LYMPHOCYTE COUNT DECREASED 2 0.0001
709 HEAD DISCOMFORT 2 0.0001
710 EXPOSURE DURING PREGNANCY 7 0.0001
711 DYSPEPSIA 11 0.0001
712 GOUT 2 0.0001
713 PAIN OF SKIN 3 0.0001
714 BLOOD BILIRUBIN INCREASED 3 0.0001
715 HEART RATE INCREASED 11 0.0001
716 PALPITATIONS 13 0.0001
717 DRUG INEFFECTIVE 146 0.0001
718 LEUKOCYTOSIS 2 0.0001
719 PALLOR 3 0.0001
720 DEVICE DELIVERY SYSTEM ISSUE 3 0.0001
721 NEPHROLITHIASIS 5 0.0001
722 PAIN IN EXTREMITY 32 0.0001
723 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 22 0.0001
724 HYPOKALAEMIA 5 0.0001
725 PROCEDURAL PAIN 3 0.0001
726 PNEUMONIA 35 0.0001
727 INFLUENZA 12 0.0001
728 CHEST DISCOMFORT 11 0.0001
729 EMOTIONAL DISTRESS 13 0.0001
730 THINKING ABNORMAL 2 0.0001
731 COGNITIVE DISORDER 5 0.0001
732 DIARRHOEA HAEMORRHAGIC 1 0.0001
733 HEPATIC CIRRHOSIS 2 0.0001
734 TARDIVE DYSKINESIA 3 0.0001
735 ARTERIOSCLEROSIS 1 0.0001
736 MULTIPLE ORGAN DYSFUNCTION SYNDROME 3 0.0001
737 ARTHRALGIA 44 0.0001
738 FRACTURE 2 0.0001
739 MUSCULAR WEAKNESS 12 0.0001
740 DYSPHAGIA 10 0.0001
741 MUSCULOSKELETAL DISORDER 2 0.0001
742 VOMITING 49 0.0001
743 LOWER LIMB FRACTURE 2 0.0001
744 DIZZINESS POSTURAL 1 0.0001
745 NEEDLE ISSUE 3 0.0001
746 ATRIAL FIBRILLATION 10 0.0001
747 HAEMORRHOIDS 2 0.0001
748 CHILLS 12 0.0001
749 LABORATORY TEST ABNORMAL 3 0.0001
750 URINARY INCONTINENCE 3 0.0001
751 EMBEDDED DEVICE 1 0.0001
752 HAEMATOCRIT DECREASED 2 0.0001
753 PRESCRIBED UNDERDOSE 2 0.0001
754 BRAIN INJURY 1 0.0001
755 PSORIASIS 13 0.0001
756 PRODUCT PHYSICAL ISSUE 2 0.0001
757 INTENTIONAL SELF-INJURY 2 0.0001
758 FATIGUE 77 0.0001
759 FEEDING DISORDER 2 0.0001
760 DRUG LEVEL DECREASED 1 0.0001
761 THERAPY INTERRUPTED 7 0.0001
762 INJECTION SITE RASH 3 0.0001
763 EAR DISCOMFORT 1 0.0001
764 EMOTIONAL DISORDER 3 0.0001
765 NERVOUS SYSTEM DISORDER 3 0.0001
766 DRUG ABUSE 8 0.0001
767 PULMONARY HYPERTENSION 2 0.0001
768 RHABDOMYOLYSIS 4 0.0001
769 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 5 0.0001
770 MUSCULOSKELETAL PAIN 5 0.0001
771 MOUTH ULCERATION 2 0.0001
772 DECREASED APPETITE 22 0.0001
773 DIARRHOEA 61 0.0001
774 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 17 0.0001
775 DYSGEUSIA 7 0.0001
776 WEIGHT INCREASED 21 0.0001
777 EPISTAXIS 7 0.0001
778 RECTAL HAEMORRHAGE 4 0.0001
779 SKIN CANCER 2 0.0001
780 INCORRECT PRODUCT ADMINISTRATION DURATION 2 0.0001
781 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
782 ABDOMINAL PAIN UPPER 19 0.0001
783 BACK INJURY 1 0.0001
784 DIABETES MELLITUS 7 0.0001
785 CHOLELITHIASIS 3 0.0001
786 EYE DISORDER 3 0.0001
787 ASTHENIA 34 0.0001
788 COLITIS ULCERATIVE 4 0.0001
789 THERAPEUTIC PRODUCT EFFECT DECREASED 4 0.0001
790 COUGH 25 0.0001
791 ANAEMIA 17 0.0001
792 TYPE 2 DIABETES MELLITUS 3 0.0001
793 BLISTER 5 0.0001
794 VISUAL IMPAIRMENT 11 0.0001
795 MYALGIA 15 0.0001
796 PRODUCT AVAILABILITY ISSUE 2 0.0001
797 CHOLECYSTECTOMY 1 0.0001
798 THROMBOSIS 7 0.0001
799 ELECTROLYTE IMBALANCE 1 0.0001
800 RASH MACULAR 3 0.0001
801 BLOOD CHOLESTEROL INCREASED 4 0.0001
802 CARDIAC DISORDER 8 0.0001
803 HYPOXIA 3 0.0001
804 DRUG DOSE OMISSION 14 0.0001
805 PERIPHERAL SWELLING 13 0.0001
806 BLOOD IRON DECREASED 1 0.0001
807 PRODUCT ADHESION ISSUE 3 0.0001
808 BLOOD PRESSURE FLUCTUATION 2 0.0001
809 WHITE BLOOD CELL COUNT DECREASED 9 0.0001
810 CONSTIPATION 18 0.0001
811 CYTOPENIA 1 0.0001
812 INJECTION SITE URTICARIA 2 0.0001
813 ALOPECIA 16 0.0001
814 CHEST PAIN 15 0.0001
815 ABASIA 2 0.0001
816 AGEUSIA 2 0.0001
817 PNEUMONIA ASPIRATION 2 0.0001
818 INTESTINAL OBSTRUCTION 3 0.0001
819 DYSPNOEA 45 0.0001
820 DERMATITIS ALLERGIC 1 0.0001
821 HAEMATEMESIS 2 0.0001
822 HYPOPHAGIA 2 0.0001
823 HOSPITALISATION 12 0.0001
824 INFLAMMATION 4 0.0001
825 EXPOSURE VIA SKIN CONTACT 2 0.0001
826 HAEMORRHAGE 8 0.0001
827 SPEECH DISORDER 4 0.0001
828 APPLICATION SITE ERYTHEMA 2 0.0001
829 GASTRITIS 2 0.0001
830 DERMATITIS ATOPIC 4 0.0001
831 DEPRESSED LEVEL OF CONSCIOUSNESS 3 0.0001
832 OROPHARYNGEAL PAIN 7 0.0001
833 ADVERSE REACTION 1 0.0001
834 PRODUCT USE ISSUE 14 0.0001
835 FEAR 2 0.0001
836 JAUNDICE 2 0.0001
837 EXTRA DOSE ADMINISTERED 3 0.0001
838 BLINDNESS 3 0.0001
839 INFLUENZA LIKE ILLNESS 6 0.0001
840 RENAL IMPAIRMENT 6 0.0001
841 OXYGEN SATURATION DECREASED 4 0.0001
842 INJURY 5 0.0001
843 RASH 31 0.0001
844 BLINDNESS UNILATERAL 1 0.0001
845 DIALYSIS 1 0.0001
846 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 5 0.0001
847 BRONCHOSPASM 1 0.0001
848 RED BLOOD CELL COUNT DECREASED 2 0.0001
849 ANGINA PECTORIS 2 0.0001
850 CARDIOGENIC SHOCK 1 0.0001
851 DEVICE LEAKAGE 3 0.0001
852 INFECTION 10 0.0001
853 ANOSMIA 1 0.0001
854 DEVICE DISLOCATION 3 0.0001
855 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
856 BONE PAIN 4 0.0001
857 HAEMOGLOBIN DECREASED 7 0.0001
858 ASCITES 2 0.0001
859 CARDIOMYOPATHY 1 0.0001
860 PRURITUS 26 0.0001
861 COLON CANCER 1 0.0001
862 PULMONARY OEDEMA 3 0.0001
863 GASTROINTESTINAL DISORDER 6 0.0001
864 THROAT IRRITATION 3 0.0001
865 RESPIRATORY DISORDER 2 0.0001
866 CORONARY ARTERY DISEASE 2 0.0001
867 BLOOD COUNT ABNORMAL 1 0.0001
868 STOMATITIS 4 0.0001
869 PLEURAL EFFUSION 4 0.0001
870 PLATELET COUNT DECREASED 7 0.0001
871 URTICARIA 11 0.0001
872 DRUG DISPENSING ERROR 1 0.0001
873 DRUG ADMINISTRATION ERROR 2 0.0001
874 INJECTION SITE ERYTHEMA 8 0.0001
875 ABDOMINAL PAIN 15 0.0001
876 RENAL DISORDER 3 0.0001
877 EJECTION FRACTION DECREASED 1 0.0001
878 PYREXIA 22 0.0001
879 ERYTHEMA 13 0.0001
880 MYOCARDIAL INFARCTION 11 0.0001
881 OFF LABEL USE 55 0.0001
882 RASH ERYTHEMATOUS 3 0.0001
883 MOOD SWINGS 2 0.0001
884 MULTIPLE SCLEROSIS 3 0.0001
885 ABSCESS 1 0.0001
886 BLOOD GLUCOSE DECREASED 3 0.0001
887 MOVEMENT DISORDER 2 0.0001
888 HYPOGLYCAEMIA 3 0.0001
889 SWELLING FACE 4 0.0001
890 IMPAIRED HEALING 2 0.0001
891 CYTOMEGALOVIRUS INFECTION 1 0.0001
892 SYNCOPE 6 0.0001
893 HYPERSENSITIVITY 11 0.0001
894 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
895 DISEASE PROGRESSION 7 0.0001
896 GASTRIC DISORDER 2 0.0001
897 MUSCULOSKELETAL STIFFNESS 5 0.0001
898 HEART RATE DECREASED 2 0.0001
899 INCORRECT DOSE ADMINISTERED 13 0.0001
900 COLD SWEAT 1 0.0001
901 SYSTEMIC LUPUS ERYTHEMATOSUS 2 0.0001
902 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 4 0.0001
903 INCORRECT ROUTE OF DRUG ADMINISTRATION 2 0.0001
904 MOBILITY DECREASED 4 0.0001
905 ADVERSE DRUG REACTION 5 0.0001
906 RASH PRURITIC 3 0.0001
907 WRONG TECHNIQUE IN DRUG USAGE PROCESS 2 0.0001
908 BONE DISORDER 1 0.0001
909 ACCIDENTAL OVERDOSE 2 0.0001
910 HAEMATOCHEZIA 3 0.0001
911 ANAPHYLACTIC REACTION 3 0.0001
912 BLOOD GLUCOSE ABNORMAL 1 0.0001
913 ARTHROPATHY 3 0.0001
914 SEPSIS 6 0.0001
915 EYE SWELLING 2 0.0001
916 HYPONATRAEMIA 3 0.0001
917 BLOOD URINE PRESENT 1 0.0001
918 PULMONARY EMBOLISM 5 0.0001
919 INJECTION SITE SWELLING 4 0.0001
920 EYE IRRITATION 3 0.0001
921 ACUTE RESPIRATORY FAILURE 1 0.0001
922 DRUG INTOLERANCE 5 0.0001
923 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
924 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
925 COMPLICATION OF DEVICE INSERTION 1 0.0001
926 DRUG DEPENDENCE 8 0.0000
927 BONE MARROW FAILURE 1 0.0000
928 ALANINE AMINOTRANSFERASE INCREASED 3 0.0000
929 POLLAKIURIA 2 0.0000
930 ABDOMINAL DISTENSION 5 0.0000
931 DERMATITIS 1 0.0000
932 SKIN EXFOLIATION 4 0.0000
933 EATING DISORDER 1 0.0000
934 PRODUCT DOSE OMISSION 3 0.0000
935 APPLICATION SITE PAIN 1 0.0000
936 LIVER DISORDER 2 0.0000
937 DRUG INTERACTION 7 0.0000
938 APPLICATION SITE PRURITUS 1 0.0000
939 INJECTION SITE REACTION 3 0.0000
940 SKIN DISCOLOURATION 2 0.0000
941 ADVERSE EVENT 4 0.0000
942 DISEASE RECURRENCE 2 0.0000
943 DIABETIC KETOACIDOSIS 1 0.0000
944 ENCEPHALOPATHY 1 0.0000
945 PRODUCT USE IN UNAPPROVED INDICATION 10 0.0000
946 DRUG RESISTANCE 1 0.0000
947 DEAFNESS 1 0.0000
948 PANCREATITIS 2 0.0000
949 BRADYCARDIA 2 0.0000
950 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
951 INJECTION SITE HAEMORRHAGE 3 0.0000
952 DRY SKIN 5 0.0000
953 BREAST CANCER FEMALE 1 0.0000
954 GASTROINTESTINAL HAEMORRHAGE 3 0.0000
955 THROMBOCYTOPENIA 4 0.0000
956 CEREBROVASCULAR ACCIDENT 6 0.0000
957 DEATH 30 0.0000
958 HERPES ZOSTER 2 0.0000
959 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
960 GENERAL PHYSICAL HEALTH DETERIORATION 4 0.0000
961 ACUTE MYOCARDIAL INFARCTION 1 0.0000
962 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
963 ILL-DEFINED DISORDER 2 0.0000
964 EPILEPSY 1 0.0000
965 INJECTION SITE PAIN 10 0.0000
966 BLOOD GLUCOSE INCREASED 6 0.0000
967 RHINORRHOEA 2 0.0000
968 FEBRILE NEUTROPENIA 2 0.0000
969 NEOPLASM MALIGNANT 2 0.0000
970 ACCIDENTAL EXPOSURE TO PRODUCT 3 0.0000
971 DEVICE MALFUNCTION 2 0.0000
972 CEREBRAL HAEMORRHAGE 1 0.0000
973 C-REACTIVE PROTEIN INCREASED 1 0.0000
974 UNDERDOSE 2 0.0000
975 RHEUMATOID ARTHRITIS 3 0.0000
976 INJECTION SITE BRUISING 2 0.0000
977 ABORTION SPONTANEOUS 1 0.0000
978 JOINT SWELLING 3 0.0000
979 CARDIO-RESPIRATORY ARREST 1 0.0000
980 PRODUCT STORAGE ERROR 2 0.0000
981 NO ADVERSE EVENT 4 0.0000
982 NEUTROPENIA 3 0.0000
983 BREAST CANCER 2 0.0000
984 ARRHYTHMIA 1 0.0000
985 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
986 CONVULSION 1 0.0000
987 DEEP VEIN THROMBOSIS 1 0.0000
988 BLOOD CREATININE INCREASED 1 0.0000
989 DRUG DOSE OMISSION BY DEVICE 1 0.0000
990 DEVICE ISSUE 1 0.0000